Congenital achromatopsia is a stationary retinal disorder with
autosomal recessive inheritance that is characterized by loss of color
discrimination, low visual acuity, photophobia, and nystagmus. This
disorder has been shown to be associated with CNGA3,
CNGB3, and GNAT2 mutations, and the frequency of
mutations in the CNGA3 gene (encoding α subunit of the
cone-specific cGMP-gated cation channel) was 23–33% in European
populations. The aim of this study was to test the hypothesis that
CNGA3 mutations are also responsible for congenital achromatopsia
in Japanese patients. DNA from venous blood samples from a total of 14
patients from 13 Japanese pedigrees was prepared. Mutation screening of
the CNGA3 gene was performed using direct sequencing and
PCR-single-strand conformation polymorphism analysis. Compound
heterozygous missense mutations (p.R436W and p.L633P, the latter of which
was novel) were identified in one patient only, a 22-year-old female.
Neither of these two mutations was found in 150 Japanese control
individuals. The patient's parents and sister carried one of these
mutations each but were not affected. No mutations in the CNGB3
or GNAT2 genes were identified in the patient. Clinically,
best-corrected visual acuity was 0.1 in both eyes. No specific findings
were obtained in funduscopy. Optical coherence topography revealed a
normal foveal thickness but a 20% decrease in parafoveal thickness.
Ganzfeld full-field electroretinograms (ERGs) showed normal responses in
rod and mixed rod-plus-cone ERGs but no response in cone or 30-Hz flicker
ERGs. Spectral sensitivity on a white background revealed a curve with
only one peak at around 500 nm, which fits the absorption spectrum of
human rhodopsin. L633, conserved among vertebrate orthologs of human
CNGA3, is a hydrophobic residue forming part of the carboxy-terminal
leucine zipper (CLZ) domain, which is functionally important in the
mediation of intracellular interactions. To our knowledge, this is the
first report of a Japanese complete achromat with CNGA3
mutations, and of any patient with a missense mutation within the CLZ
domain. The outcome suggests low frequency (7%, 1/14) of
CNGA3 mutations in Japanese patients.